Intellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation. An international group of scholars from a range of disciplines – economic geography, health law, business, philosophy, history, public health, management – examine how IPRs actually operate in innovation systems, not just from the perspective of theory but grounded in their global, regional, national, current and historical contexts. In so doing, the contributors seek to uncover and move beyond deeply held assumptions about the role of IPRs in innovation systems. Scholars and students interested in innovation, science and technology policy, intellectual property rights and technology transfer will find this volume of great interest. The findings will also be of value to decision makers in science and technology policy and managers of intellectual property in biotechnology and venture capital firms.
Bibliography, etc. Note
Includes bibliographical references and index.
Formatted Contents Note
Introduction Part I: Intellectual Property Rights in Innovation Systems – Introduction; 1. Are Intellectual Property Rights Quanta of Innovation?; 2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context; 3. Intellectual Property Rights Policy for Gene-Related Inventions – Toward Optimum Balance Between Public and Private Ownership Part II: Intellectual Property Management In Biotechnology – Introduction; 4. Fundamentals of Intellectual Property Management; 5. Making a Return on R&D: A Business Perspective; 6. Looking Beyond the Firm: Intellectual Asset Management and Biotechnology Part III: Intellectual Property Rights in Relation to Other Measures of Innovation – Introduction; 7. Increasing Internal Value from Patents: The Role of Organizational Arrangements; 8. Language System (LS) 3.0: An Agenda for a Model of Innovation Valuation; 9. Measurement of Innovation and Intellectual Property Management: Challenging Processes Part IV: Beyond Patent Length – Introduction; 10. Open Development: Is the ‘Open Source’ Analogy Relevant to Biotechnology?; 11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific Benefits; 12. On the Comparative Institutional Economics of Intellectual Property in Biotechnology Part V: Innovation Governance – Introduction; 13. Accessibility of Biological Data: A Role for the European Database Right?; 14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance?; 15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing Countries Part VI: National, International and Historical Comparisons – Introduction; 16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International Comparisons; 17. Intellectual Property, Information and Divergences in Economic Development – Institutional Patterns and Outcomes circa 1421–2000; 18. Watch What You Export: The History of Medical Exceptions from Patentability Index